瑞典研究发现,首次跳过乳腺癌筛查后,终生死亡风险将增加40%。 Skipping first breast cancer screening raises lifetime death risk by 40%, Swedish study finds.

超过第一次乳腺癌筛查的妇女终生死于该疾病的风险要高40%。 瑞典的一项大型研究发表在《BMJ》中。 Women who skip their first breast cancer screening face a 40% higher lifetime risk of dying from the disease, a large Swedish study published in the BMJ shows. 研究人员对1991年至2020年期间应邀接受初步乳房X光检查的近50万妇女进行了分析,发现32%的妇女没有参加,这些妇女更有可能被诊断患有晚期癌症,更不可能参加今后的筛查。 Analyzing nearly half a million women invited to initial mammograms between 1991 and 2020, researchers found that 32% did not attend, and these women were more likely to be diagnosed with advanced cancer and less likely to attend future screenings. 虽然癌症发病率相似,但延迟发现导致死亡率较高。 While cancer incidence was similar, delayed detection led to higher death rates. 调查结果强调第一次筛查是长期预防的重要机会,敦促加强外联和支持,以促进参与和降低死亡率。 The findings highlight the first screening as a critical opportunity for long-term prevention, urging improved outreach and support to boost participation and reduce mortality.